How Many Lines of Therapy Do Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receive in Routine Clinical Practice in the United States? Real World Evidence From the Targeted Therapy Era

Clinical Lymphoma, Myeloma & Leukemia · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles